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Abstract
Host defense peptides (HDPs) constitute a large group of natural broad-spectrum antimicrobials and an important first line
of immunity in virtually all forms of life. Specific augmentation of synthesis of endogenous HDPs may represent a promising
antibiotic-alternative approach to disease control. In this study, we tested the hypothesis that exogenous administration of
butyrate, a major type of short-chain fatty acids derived from bacterial fermentation of undigested dietary fiber, is capable
of inducing HDPs and enhancing disease resistance in chickens. We have found that butyrate is a potent inducer of several,
but not all, chicken HDPs in HD11 macrophages as well as in primary monocytes, bone marrow cells, and jejuna and cecal
explants. In addition, butyrate treatment enhanced the antibacterial activity of chicken monocytes against Salmonella
enteritidis, with a minimum impact on inflammatory cytokine production, phagocytosis, and oxidative burst capacities of the
cells. Furthermore, feed supplementation with 0.1% butyrate led to a significant increase in HDP gene expression in the
intestinal tract of chickens. More importantly, such a feeding strategy resulted in a nearly 10-fold reduction in the bacterial
titer in the cecum following experimental infections with S. enteritidis. Collectively, the results indicated that butyrate-
induced synthesis of endogenous HDPs is a phylogenetically conserved mechanism of innate host defense shared by
mammals and aves, and that dietary supplementation of butyrate has potential for further development as a convenient
antibiotic-alternative strategy to enhance host innate immunity and disease resistance.
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Introduction
Host defense peptides (HDPs), also known as antimicrobial
peptides, are present in virtually all species of life and constitute a
critical component of the innate immunity [1,2,3,4,5]. Defensins
and cathelicidins represent two major families of HDPs in
vertebrates [6,7,8,9,10,11]. While defensins are categorized by
the presence of six conserved cysteine residues in the C-terminal
mature sequence [6,7,8,11], all cathelicidins consist of a
conserved cathelin domain in the pro-sequence with a highly
diversified C-terminal mature sequence [9,10]. The chicken
genome was recently found to encode a total of 14 b-defensins
known as AvBD1-14 [12,13,14] and four cathelicidins, namely
fowlicidins 1–3 [12,15,16] and cathelicidin-B1 [17]. All AvBDs
are densely clustered on chicken chromosome 3q [13,14],
whereas cathelicidin genes are located on chromosome 2p
[16,17]. Both chicken AvBDs and cathelicidins are expressed in
a wide range of tissues, with cathelicidins expressed most
abundantly in the bone marrow or bursa [15,16,17] and b-
defensins in the liver and throughout the digestive, respiratory,
and reproductive tracts [12,14].
HDPs possess broad-spectrum antimicrobial activities against
bacteria, protozoa, enveloped virus, and fungi mainly through
direct binding and lysis of microbial membranes [5,18]. Because
of such physical interactions, it is extremely difficult for
pathogens to develop resistance to HDPs. Many chicken HDPs
such as AvBD9 (formally known as gallinacin-6) and cathelicidin
B1 have been found to possess potent antibacterial activities
against a broad range of bacteria including Salmonella
[16,19,20,21,22,23,24,25]. Besides direct microbicidal activities,
HDPs have a strong capacity to modulate the innate immune
response by inducing chemotaxis and activation of various types
of leukocytes [2,4]. Because of these pleiotropic effects, HDPs
have been actively explored as a new class of therapeutic agents
against antibiotic-resistant microbes and other inflammatory
diseases [2,5].
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27225Butyrate, a major species of short-chain fatty acids produced by
bacterial fermentation of undigested carbohydrates in the intestine
[26,27], was recently found to be capable of inducing HDP
expression in humans and rabbits [28,29,30]. To test whether
butyrate can augment HDP gene expression in a non-mammalian
species, we studied the effect of butyrate on HDP gene expression
and the antibacterial activity of monocytes in the chicken.
Furthermore, we examined the effect of supplementing butyrate
in the feed on the titer of Salmonella enteritidis in the cecum following
experimental infections. We concluded that butyrate-mediated
induction of HDP synthesis is phylogenetically conserved in both
mammals and aves. Additionally, butyrate may be further
exploited as a cost-effective feed or food additive in enhancing
host immunity and disease resistance.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
animal procedures reported herein were approved by the
Institutional Animal Care and Use Committee of Oklahoma
State University under protocol no. AG0610. Prior to sample
collection, chickens were euthanized by an intramuscular injection
of a cocktail of ketamine/xylazine, followed by cervical dislocation
to minimize pain.
Isolation, culture, and stimulation of chicken cells and
intestinal tissue explants
Chicken HD11 macrophage cells [31] were cultured in
complete RPMI 1640 containing 10% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 mg/ml streptomycin, and seeded at
2610
6 cells/well in 6-well cell culture plates overnight, prior to
stimulation with different concentrations of sodium butyrate
(Sigma) in duplicate and incubated at 37uC and 5% CO2 for
indicated times. Chicken peripheral blood mononuclear cells
(PBMCs) were isolated from EDTA-anticoagulated venous blood
of adult layers through gradient centrifugation using Histopaque
1077 (Sigma). Monocytes were obtained by seeding PBMCs at
3610
7 cells/well in 6-well plates overnight and washing off non-
adherent cells twice with calcium- and magnesium-free Hank’s
balanced salt solution (HBSS). Monocytes were replenished with
fresh complete RPMI 1640 prior to stimulation with sodium
butyrate. Bone marrow cells were collected from femur bones of 1-
to 2-week-old broiler chickens, lysed of erythrocytes, and cultured
at 1610
7 cells in 60-mm tissue culture dishes in RPMI 1640
containing 20 mM HEPES, 10% FBS, 100 U/ml penicillin, and
100 mg/ml streptomycin, followed by butyrate stimulation. Jejunal
and cecal explants were obtained by washing thoroughly a
segment of the jejunum and cecum of 1- to 2-week-old broiler
chickens with cold HBSS containing 50 mg/ml of gentamicin,
followed by slicing in a series of 0.5-cm long segments and placing
individually in 6-well tissue culture plates in RPMI 1640
Table 1. Primer sequences of chicken host defense peptides and cytokines for real time PCR
a.
Gene Forward primer Reverse primer Product size(bp)
cDNA Gene
AvBD1 ATGCGGATCGTGTACCTGCTC CTGCTTGGGATGTCTGGCTCT 219 1197
AvBD2 CTCTCTCCTCTTCCTGGCAC GAGGGGTCTTCTTGCTGCTG 265 1122
AvBD3 ATGCGGATCGTGTACCTGCTC CAGAATTCAGGGCATCAACCTC 196 2379
AvBD4 CATCTCAGTGTCGTTTCTCTGC ACAATGGTTCCCCAAATCCAAC 321 899
AvBD5 CTGCCAGCAAGAAAGGAACCTG TGAACGTGAAGGGACATCAGAG 300 1100
AvBD6 AGGATTTCACATCCCAGCCGTG CAGGAGAAGCCAGTGAGTCATC 249 1203
AvBD7 CTGCTGTCTGTCCTCTTTGTGG CATTTGGTAGATGCAGGAAGGA 230 665
AvBD8 TTCTCCTCACTGTGCTCCAA AAGGCTCTGGTATGGAGGTG 124 383
AvBD9 GCAAAGGCTATTCCACAGCAG AGCATTTCAGCTTCCCACCAC 211 1802
AvBD10 TGGGGCACGCAGTCCACAAC ATCAGCTCCTCAAGGCAGTG 298 2285
AvBD11 ACTGCATCCGTTCCAAAGTCTG TCGGGCAGCTTCTCTACAAC 301 1299
AvBD12 CCCAGCAGGACCAAAGCAATG GTGAATCCACAGCCAATGAGAG 335 731
AvBD13 CATCGTTGTCATTCTCCTCCTC ACTTGCAGCGTGTGGGAGTTG 175 4514
AvBD14 CTCCTGTTTCTTGTTCTCCTG CACTTTGCCAGTCCATTGTAG 149 501
Cath-B1 CCGTGTCCATAGAGCAGCAG AGTGCTGGTGACGTTCAGATG 170 251
Fowlicidin-1 GCTGTGGACTCCTACAACCAAC GGAGTCCACGCAGGTGACATC 261 882
Fowlicidin-2 CAAGGAGAATGGGGTCATCAG CGTGGCCCCATTTATTCATTCA 221 584
Fowlicidin-3 GCTGTGGACTCCTACAACCAAC TGGCTTTGTAGAGGTTGATGC 352 1095
IL-1b GACATCTTCGACATCAACCAG CCGCTCATCACACACGACAT 215 384
IL-8 GCTGATCGTAAAGGCACTTATG GTGAAAGGTGGAAGATGGAATG 159 727
IL-12p40 GACCCACCTCAATGTCAGTATG GCCCAGTCTTTGGAATCTGAAT 184 1456
GAPDH GCACGCCATCACTATCTTCC CATCCACCGTCTTCTGTGTG 356 876
aPrimers for AvBD4-13 and GAPDH are adopted from reference 14.
doi:10.1371/journal.pone.0027225.t001
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100 mg/ml streptomycin, and 50 mg/ml gentamicin. Jejunal and
cecal explants were cultured at 37uC and 5% CO2 in the presence
of different concentrations of sodium butyrate in duplicate for
24 h.
Real-time RT-PCR analysis of chicken HDP gene
expression
Following treatment with sodium butyrate, chicken cells and
tissue explants were lysed in Tri Reagent (Sigma) for extraction of
total RNA. The first-strand cDNA was synthesized from 300 ng of
total RNA using QuantiTect Reverse Transcription Kit (Qiagen)
in a total volume of 4 ml. Real-time PCR was then performed
using QuantiTect SYBR Green PCR kit (Qiagen) and MyiQ
Real-Time PCR Detection System (Bio-Rad) in 10 ml reactions
containing 1/40 or 1/20 of the first-strand cDNA and gene-
specific primers for 14 AvBDs, 4 chicken cathelicidins, and
multiple cytokines (Table 1) as described [16,25,32]. PCR cycling
conditions were 95uC for 10 min, followed by 45 cycles of 94uC
for 15 sec, 55uC for 20 sec, and 72uC for 30 sec. The specificity of
PCR reaction was confirmed by the melt curve analysis. The gene
expression levels were quantified using the comparative DDCt
method with the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene as a reference for normalization.
Cell cytotoxicity of butyrate in HD11 cells
The cytotoxicity assay was performed as described previously
[25,32,33]. Briefly, HD11 cells (1610
5) were seeded overnight in
96-well tissue culture plates. Butyrate was added in duplicate from
0 to 16 mM for 18 h, following by addition of 10% of alamarBlue
(Invitrgoen) for another 6 h. The fluorescence was read at 545 nm
excitation and 590 nm emission. Cell death (%) was calculated
as [12(Fbutyrate2Fbackground)/(Fcontrol2Fbackground)]6100, where
Fbutyrate is the fluorescence of cells exposed to different
concentrations of butyrate, Fcontrol is the fluorescence of cells
only, and Fbackground is the background fluorescence of 10%
alamarBlue in cell culture medium without cells.
Antibacterial activity of monocytes treated with butyrate
Following overnight adherence of PBMCs to cell culture dishes,
chicken monocytes were replenished with fresh antibiotic-free
RPMI 1640 and incubated with 0, 0.5, 1, 2, and 4 mM of sodium
butyrate for 24 h. Cells were then scraped, stored at 280uC
overnight, lysed with 1% Triton X-100, and centrifuged at
12,0006 g for 10 min at 4uC. Serial 2-fold dilutions were then
prepared from the cell supernatants and incubated with
2610
4 CFU of Salmonella enteritidis (ATCC 13076) in 20%
Trypticase Soy Broth containing 1 mM NaH2PO4 and 25 mM
NaHCO3 for 9 h in a 96-well plate at 37uC as described [34].
Bacterial turbidity was measured at OD590 nm using an ELISA
plate reader. Different concentrations of sodium butyrate were
Figure 1. Butyrate-induced expression of the AvBD9 gene in
different chicken cell types. HD11 macrophage cells were incubated
in duplicate with 4 mM sodium butyrate for indicated time points (A) or
indicated concentrations of butyrate for 24 h (B). Chicken primary
monocytes (C) or bone marrow cells (D) were exposed to different
concentrations of butyrate in duplicate for 24 h prior to isolation of
total RNA. The AvBD9 gene expression was analyzed by real-time RT-
PCR, and the relative fold increase over the control group was
calculated using the comparative DDCt method and the GAPDH gene
for normalization. The bars represent means 6 standard error of the
data from 2–3 independent experiments.
doi:10.1371/journal.pone.0027225.g001
Figure 2. Induction of HDP gene expression in chicken HD11
macrophages and primary monocytes. Chicken HD11 macrophage
cells and primary monocytes were incubated in duplicate with and
without different concentrations of butyrate for 24 h, followed by RNA
isolation and real-time RT-PCR analysis of all 14 chicken b-defensins
(AvBDs) and 4 cathelicidins (fowlicidins 1–3 and cathelicidin B1). The
color elements represent average log2 ratios of fold change from 2–3
independent experiments. Red indicates up-regulation, whereas black
means no induction and green down-regulation. Gray areas are an
indication of no data due to extremely low expression levels of certain
HDPs in primary monocytes. Three groups of chicken HDPs, namely
generally induced (I), non-regulatable (II), and generally down-regulated
(III), can be classified according to their mode of modulation by
butyrate. AvBD11, AvBD12, and AvBD13 could not be reliably detected in
either cell type, and therefore, were not shown. The heat map was
generating by using MultiExperiment Viewer [48].
doi:10.1371/journal.pone.0027225.g002
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measure turbidity after 9 h incubation.
Phagocytosis assay of HD11 cells
Phagocytosis of S. enteritidis phage type 13a by HD11 cells was
measured as described with slight modifications [35]. After seeding
6610
6 cells in complete RPMI 1640 overnight in 60-mm tissue
culture plates, HD11 cells were stimulated with and without 0.5, 1
or 2 mM sodium butyrate for 24 h. Cells (2.5610
6) were then
incubated with 2.5610
7 CFU of S. enteritidis phage type 13a in
1 ml RPMI 1640 containing 5% chicken serum for 30 min at
37uC. To kill extracellular bacteria, cells were washed twice with
ice-cold HBSS, re-suspended with 1 ml RPMI 1640 containing
100 mg/ml gentamicin for 1 h at 37uC. Cells were then lysed by
incubating with 1% Triton X-100 for 15 min, serially diluted, and
spread on Brilliant Green agar plates (Becton Dickinson)
containing 20 mg/ml of nalidixic acid and incubated overnight
at 37uC for enumeration.
Oxidative burst assay of HD11 cells
The assay of oxidative burst activity was performed as
previously described with slight modifications [36]. Briefly,
HD11 cells were seeded at 1610
5 cells in a 96-well plate in
complete RPMI 1640 and cultured overnight. After addition of 0,
0.5, 1, and 2 mM of sodium butyrate for 24 h, cells were washed
with HBSS to remove antibiotics, replenished with fresh RPMI
1640 free of Phenol Red and antibiotics, and rested for 30 min.
Phorbol 12-myristate 13-acetate (PMA, Sigma) and 29,79-dichlor-
odihydrofluorescein diacetate (DCFDA, Sigma) were added to
cells to final concentrations of 0.5 mg/ml and 10 mM, respectively.
The fluorescence was monitored at 485 nm excitation and
528 nm emission using FLx800 Multi-Detection Microplate
Reader (Bio-Tek Instruments) 1 h after incubation at 37uC. The
results were normalized against protein concentrations, which
were measured using the Bradford assay (Bio-Rad) as per
manufacturer’s instructions.
Flow cytometric analysis of MHC class I and II surface
markers
Following stimulation with 4 mM butyrate, 1 mg/ml LPS from
E. coli O111:B4 (Sigma) or left untreated for 24 h, HD11 cells were
Figure 3. Up-regulation of three representative HDPs in chicken jejunal (A) and cecal explants (B) by butyrate. Chicken jejunum and
cecal explants were obtained by culturing slices of 0.5 cm long segments, followed by incubation with indicated concentrations of butyrate in
duplicate for 24 h. Real time RT-PCR was performed and the relative fold increase over the control group was calculated using the comparative DDCt
method and the GAPDH gene for normalization. The bars represent means 6 standard error of the data from two independent experiments.
doi:10.1371/journal.pone.0027225.g003
Figure 4. In vivo induction of the AvBD9 gene expression in the
intestinal tract of chickens by butyrate. Two-day-old male Cornish
Rock broilers were fed with standard ration with or without
supplementation of 0.1% and 0.2% butyrate for 2 days. The crop, cecal
tonsil, and cecum were collected from each chicken and the AvBD9
gene expression was evaluated by real-time PCR. Each bar represents
means 6 standard error of the data from 6 different chickens. * P,0.05
by unpaired Student’s t-test.
doi:10.1371/journal.pone.0027225.g004
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6/ml with the FACS buffer
(0.1% BSA+0.02% sodium azide in phosphate buffered saline).
Cells were preincubated in the FACS buffer containing 1%
chicken serum and 1% of rat FCc III/II receptor blocker (clone
2.4G2, eBioscience) for 15 min, followed by incubation with
fluorescein isothiocyanate (FITC)-conjugated mouse anti-chicken
MHC class I (clone F21-2, SouthernBiotech) and R-phycoery-
thrin (R-PE)-conjugated mouse anti-chicken MHC class II (clone
2G11, SouthernBiotech) monoclonal antibodies for another
30 min. Flow cytometry was performed on a FACSCalibur Flow
Cytometer (Becton-Dickinson) and analyzed with BD CellQuest
Pro-software.
Butyrate feeding and S. enteritidis infection of chickens
Two chicken trials were conducted to test the in vivo effect of
butyrate on HDP gene expression and disease resistance. In trial
1, a total of 20, five-day-old male Cornish Rock broiler chickens
(Ideal Poultry, Cameron, TX) were equally divided and fed with
a standard antibiotic-free ration mixed with or without 0.2%
sodium butyrate for 48 h prior to intraesophageal infections with
0.5 ml of Lysogeny broth (LB) containing 1610
6 CFU of S.
enteritidis phage type 13a [37]. After continuous feeding with
butyrate-supplemented feed for another 4 days, the birds were
euthanized and cecal contents were aseptically collected from
each animal, serially diluted in PBS, and plated on Brilliant
Green agar plates (Becton Dickinson) containing 20 mg/ml of
nalidixic acid for bacterial enumeration. Trial 2 was conducted
similarly with a total of 30, five-day-old male broilers fed with or
without 0.1% or 0.2% sodium butyrate supplementation in the
feed for two days, with 10 chickens per treatment. An
intraesophageal infection with 1610
6 CFU of S. enteritidis phage
type 13a was conducted 2 days later and butyrate supplemen-
tation was continued for another 4 days. Cecal contents were
then collected from each chicken for bacterial counting.
Unpaired Student’s t-test was performed among groups, and
p,0.05 was considered statistically significant.
Figure 5. Minimum triggering of proinflammatory cytokine
synthesis in HD11 cells by butyrate. Chicken HD11 macrophage
cells were incubated with indicated concentrations of butyrate or 1 mg/
ml LPS in duplicate for 3 and 24 h, followed by real-time PCR analysis of
the gene expressions of IL-1b (A), IL-12p40 (B), and IL-8 (C). The bars
represent means 6 standard error of the data from two independent
experiments. Essentially no induction of IL-1 and IL-12p40 was observed
at both 3 and 24 h after butyrate stimulation, with moderate induction
of IL-8 occurring only following butyrate treatment for 24 h.
doi:10.1371/journal.pone.0027225.g005
Figure 6. Augmentation of the antibacterial activity of
monocytes following stimulation with butyrate. Chicken mono-
cytes were treated with or without different concentrations of butyrate
for 24 h. Cell lysates were then prepared and incubated with S.
enteritidis (ATCC 13076) for 9 h at 37uC. Bacterial turbidity at OD590 nm
was measured as an indication of the bacterial density. S. enteritidis was
also directly incubated with different concentrations of butyrate in cell
culture medium alone without monocytes as controls (white bars). The
bars represent means 6 standard error of the data from two
independent experiments.
doi:10.1371/journal.pone.0027225.g006
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Butyrate induces HDP gene expression in chicken HD11
macrophage cells, primary monocytes, bone marrow
cells, and jejunal and cecal explants
To elucidate the effect of butyrate on HDP gene expression in
the chicken, we first stimulated HD11 macrophage cells and
primary chicken monocytes with different concentrations of
sodium butyrate for various times, followed by real-time RT-
PCR analysis of the expressions of the genes for all 14 AvBDs and
4 cathelicidins. The avian b-defensin 9 (AvBD9) gene was
dramatically induced in HD11 cells in a time-dependent manner
peaking at 24–48 h following stimulation with 4 mM butyrate
(Fig. 1A). A dose-dependent induction was also evident in HD11
cells, with 4 mM butyrate giving nearly 5400-fold induction of
AvBD9 after treatment for 24 h (Fig. 1B). Similarly, the AvBD9
gene expression was dose-dependently augmented in primary
monocytes, resulting in a 200- and 650-fold increase following
24 h stimulation with 4 and 8 mM butyrate, respectively (Fig. 1C).
A 700-fold augmentation of the AvBD9 gene was also observed in
chicken bone marrow cells treated with 4 mM butyrate for 24 h
(Fig. 1D). It is noteworthy that the kinetics of butyrate-mediated
HDP gene expression is similar in humans, where a peak response
occurred in intestinal cell lines 1–2 days following treatment with
4 mM butyrate [29,30]. However, it is not clear why the sensitivity
of the two chicken cell types to butyrate differs. Butyrate at 4 mM
gave an optimal induction of the AvBD9 gene in HD11 and bone
marrow cells, whereas a peak response occurred at 8 mM in
primary monocytes, although no appreciable impact on the
viability of the cells was observed in any cell type in response to up
to 8 mM butyrate (data not shown).
Besides AvBD9, several other chicken HDP genes including
cathelicidin B1, AvBD3, AvBD4, AvBD8, AvBD10, and AvBD14, also
showed largely dose-dependent inductions in response to butyrate
treatment in HD11 cells, albeit at a lesser magnitude than AvBD9
(Fig. 2). A similar trend also occurred in chicken primary
monocytes, where butyrate triggered dose-dependent up-regula-
tion of cathelicidin B1, AvBD3, AvBD5, and AvBD14 (Fig. 2).
Notably, a subset of HDP genes including AvBD1, AvBD6, and
fowlicidins 1–3 were essentially not modulated by butyrate in either
cell type (Fig. 2). Furthermore, AvBD2 and AvBD7 were even
slightly down-regulated in primary monocytes and HD11 cells,
respectively (Fig. 2), suggesting differential regulation of HDPs by
butyrate.
To further examine whether butyrate is capable of augmenting
HDP gene expression in intestinal cells, chicken jejunal and cecal
explants were prepared and stimulated with butyrate for 24 h.
Three representative HDPs, namely AvBD9, AvBD14, and
cathelicidin B1, were induced in a dose-dependent manner in both
the jejunum (Fig. 3A) and cecum (Fig. 3B), although the
magnitude of induction was generally less pronounced in the
cecum than in the jejunum.
To confirm the HDP-inducing activity of butyrate in vivo, we fed
2-day-old broiler chickens with and without 0.1% and 0.2%
butyrate in standard ration for 2 days and harvested the crop,
cecal tonsil, and cecum for real-time RT-PCR analysis of the
AvBD9 gene expression. As shown in Fig. 4, significantly induced
AvBD9 expression was observed in the crop, with 0.1% and 0.2%
butyrate leading to 22- and 7.5-fold increase, respectively. A
similar, but less dramatic trend also occurred in the cecal tonsil
and cecum (Fig. 4). It is not known why a reduced response was
seen with 0.2% butyrate supplementation compared to 0.1%
butyrate. Perhaps higher concentrations of butyrate are more
potent in inducing growth arrest and apoptosis [26,27]. The
finding that AvBD9 is induced more pronounced in the crop than
in the lower digestive tract is perhaps related to tissue specificity.
However, it is more likely because local concentrations of
supplemented butyrate are much higher in the crop than in other
parts of the intestinal tract, similar to earlier findings that the
majority of butyrate is absorbed in the crop before reaching the
lower digestive tract [38,39]. Collectively, these results strongly
suggest that butyrate is a potent inducer of the chicken HDP
expression in multiple cell types both in vivo and in vitro, although
cell- and tissue-specific induction patterns are also evident.
Butyrate triggers no or minimum inflammatory response
Butyrate generally exerts anti-inflammatory effects and has been
used to treat inflammatory bowel diseases [26,27]. To confirm
butyrate-mediated specific augmentation of HDP gene expression
without triggering a proinflammatory response, we treated HD11
cells with and without butyrate for 3 and 24 h and analyzed the
Figure 7. No impact of butyrate on phagocytic (A) or oxidative
burst activities (B) of HD11 cells. In the phagocytosis assay, chicken
HD11 macrophage cells were incubated with different concentrations
of butyrate in duplicate for 24 h, followed by exposure to S. enteritidis
phage type 13a for 30 min at 37uC in the presence of 5% chicken
serum. Extracellular bacteria were then killed by gentamicin, and
internalized bacteria were enumerated from lyzed HD11 cells by serial
plating on Brilliant Green agar plates containing 20 mg/ml nalidixic acid
overnight at 37uC. In the oxidative burst assay, HD11 cells were
stimulated with indicated concentrations of butyrate for 24 h. The
fluorescence was monitored at 485 nm excitation and 528 nm emission
following 1 h incubation with 29,79-dichlorodihydrofluorescein diace-
tate (DCFA) in the presence or absence of phorbol 12-myristate 13-
acetate (PMA). The results were normalized against protein concentra-
tions of each sample. The bars represent means 6 standard error of the
data from two independent experiments.
doi:10.1371/journal.pone.0027225.g007
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and IL-12p40. Butyrate had essentially no effect on either IL-1b
(Fig. 5A) or IL-12p40 expression (Fig. 5B) at both time points. No
influence on IL-8 expression was observed after 3 h stimulation
with a moderate induction only after 24 h (Fig. 5C). In contrast,
IL-1b, IL-8, and IL-12p40 were induced markedly in response to
1 mg/ml LPS (Fig. 5). These results demonstrated that butyrate
selectively induces HDPs with a minimum impact on proin-
flammatory cytokine expression, consistent with earlier transcrip-
tional profiling results that butyrate is generally anti-inflammatory,
suppressing expression of certain cytokines with no effect on the
majority of them [40,41].
Butyrate augments the antibacterial activity of chicken
monocytes through induction of HDPs
To investigate the functional consequence of butyrate-induced
HDP expression, we stimulated chicken primary monocytes with
andwithout differentconcentrationsofbutyratefor24 h,lysedcells,
incubated cell lysates with S. enteritidis, and measured bacterial
turbidity after 9 h. As shown in Fig. 6, a dose-dependent
suppression of bacterialgrowth in butyrate-treatedmonocyte lysates
was observed, with 4 mM butyrate giving greater than 3-fold
reduction in turbidity. It is worth noting that incubation of bacteria
with butyrate alone had not impact on bacterial growth at up to
4 mM (Fig. 6), implying that butyrate is incapable of killing bacteria
directly at the HDP-inducing concentrations. Furthermore, given
that butyrate in the cell culture medium was completely washed off
prior to cell lysis and the antibacterial assay, an enhancement in the
antibacterial activity of the cell lysates is unlikely due to the direct
bacterial killing activity of butyrate.
To further rule out the possibility that butyrate-induced
augmentation of the antibacterial activity was not attributed to a
change in phagocytosis of chicken macrophages by butyrate, we
first incubated HD11 cells with different concentrations of
butyrate for 24 h and then measured the phagocytic capacity of
the cells to S. enteritidis. In comparison with non-treated cells,
essentially no difference in phagocytosis was observed with any
concentration of butyrate (Fig. 7A). We further examined the
influence of butyrate on the oxidative burst activity of chicken
macrophages. As seen in Fig. 7B, PMA triggered a significant
oxidative burst in HD11 cells; however, butyrate had a minimum
impact on the cells treated with and without PMA.
To test whether butyrate is capable of activating chicken
macrophages, we quantified a surface marker of cell activation,
i.e., MHC class II, on HD11 cells by flow cytometry following
stimulation with 2 mM butyrate for 24 h, using MHC class I as a
house-keeping control. As expected, LPS stimulation induced
surface expression of MHC class II in nearly 50% cells; however,
essentially no change in MHC class II expression was observed in
butyrate-treated HD11 cells (Fig. 8). These results collectively
indicated that butyrate is incapable of modulating phagocytosis,
oxidative burst or activation status of macrophage cells. Augmen-
tation of the antibacterial activity in response to butyrate
treatment, therefore, is likely due to specific induction of
endogenous synthesis of HDPs.
Oral supplementation of butyrate reduces S. enteritidis
colonization in the cecum of infected chickens
Because enhanced HDP gene expression and antibacterial
activities were observed in cells in response to butyrate treatment,
we evaluated whether supplementation of feed with butyrate can
reduce the survival of pathogenic bacteria in the intestinal tract of
5-day-old broilers in two separate trials. Chickens were fed with
and without 0.1% and/or 2% butyrate for 2 days prior to
intraesophageal inoculation of S. enteritidis phage type 13a for
another 4 days. The cecal contents, where S. enteritidis most heavily
colonizes, were aseptically harvested and subjected to serial plating
on Brilliant Green agar plates containing 20 mg/ml of nalidixic
acid for specific enumeration of S. enteritidis 13a. In trial 1, oral
supplementation of 0.2% butyrate resulted in 1-log reduction in
the median counts of inoculated bacteria in the cecal content,
relative to the control group (Fig. 9A). In trial 2, 0.1% butyrate
significantly reduced bacterial load (P=0.03) in the cecal content
of the chickens, whereas 0.2% butyrate led to a less reduction of
bacterial counts (Fig. 9B). This is perhaps not surprising, given the
earlier findings that, as compared to 0.1% butyrate, 0.2% butyrate
supplementation caused less induction of the HDP genes in the
intestinal tract (Fig. 4).
Discussion
As a major species of short-chain fatty acids produced from
fermentation of undigested dietary fiber by intestinal microflora,
butyrate exerts a plethora of effects on intestinal health and disease
Figure 8. No influence on the activation status of HD11 cells by butyrate. HD11 cells were incubated with 4 mM butyrate, 1 mg/ml LPS or
left untreated for 24 h, followed by flow cytometric analysis of surface expression of MHC class I and II using fluorescein isothiocyanate (FITC)-
conjugated anti-chicken MHC class I and R-phycoerythrin (R-PE)-conjugated anti-chicken MHC class II monoclonal antibodies. The data shown are
representative of two independent experiments.
doi:10.1371/journal.pone.0027225.g008
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colonocytes in mammals, butyrate has been found to play an
important role in the digestive tract by stimulating mucin synthesis
and intestinal motility, cell proliferation and differentiation, while
suppressing inflammatory diseases [26,27,39]. In the present
study, we have revealed a novel role for butyrate in host defense
and extended earlier findings that butyrate-induced synthesis of
HDPs not only occurs in humans and rabbits [28,29,30], but is
also conserved in chickens. We have presented both in vitro and in
vivo evidence showing that butyrate strongly induces the
expressions of multiple HDPs in different cell and tissue types
including HD11 macrophages, primary monocytes, bone marrow
cells, jejunum and cecal explants as well as in crop, cecum, and
cecal tonsils of chickens. The results clearly suggest that
transcriptional regulatory mechanisms of many HDPs are
phylogenetically conserved across mammals and aves.
It is important to note that only a subset of chicken HDPs are
regulated by butyrate (Fig. 2), implying that HDPs are differen-
tially regulated even within the same family. Consistently, only LL-
37 and human b-defensin-2 were reported to be regulated by
butyrate in humans [29,30,42]. For those chicken HDP genes that
are modulated by butyrate, we observed a clear cell-specific
regulation pattern as evidenced by marked differences in the
magnitude of induction among different cell types. For example,
treatment with 4 mM butyrate for 24 h induced the AvBD9 gene
approximately 3,000- to 5,000-fold in HD11 macrophage cells,
but only 200-fold in primary monocytes, 700-fold in bone marrow
cells, 140-fold in jejunal explants, and 5-fold in cecal explants
(Figs. 1 and 3). Several other HDPs, e.g., AvBD14 and cathelicidins
B1 were also regulated differently among individual cell types
(Fig. 3 and data not shown).
Although we could not detect the synthesis of chicken HDPs at
the protein level in response to butyrate treatment due to a lack of
specific antibodies, we observed an increased HDP gene synthesis
leading to an enhanced antibacterial activity in monocytes in vitro
and augmented intestinal bacterial clearance in vivo following
butyrate treatment. A nearly 10-fold reduction in the bacterial titer
was achieved in the cecal contents of the chickens fed 0.1% or
0.2% butyrate (Fig. 9). Given the rapid rate of absorption and
metabolism, the majority of supplemented butyrate is known to be
taken up by the upper digestive tract, with very small quantities
reaching the lower intestinal tract or general circulation [38,39]. A
more pronounced reduction in the cecal bacterial titer may be
achieved if supplemented butyrate can be protected when passing
through the upper digestive tract or if more butyrate can be
produced in the cecum by manipulating the conditions of local
bacterial fermentation [38,39].
It is noteworthy that 0.1% butyrate gave a better bacterial
reduction than 0.2% butyrate in our feeding trial (Fig. 9B), in
agreement with the finding that 0.1% butyrate supplementation
led to a higher level of the AvBD9 gene transcription in the crop,
cecum, and cecal tonsil of chickens than 0.2% butyrate (Fig. 4).
Consistently, 8 mM butyrate failed to stimulate the synthesis of a
higher amount of the AvBD9 transcripts in HD11 cells than 4 mM
butyrate (Fig. 1B). In fact, higher concentrations of butyrate often
lead to cytotoxicity, growth arrest, and apoptosis [26,27,39]. The
optimal dose of butyrate for in vivo applications, therefore, needs
to be investigated carefully for each animal species.
It was reported earlier that oral supplementation of 0.63 mg/kg
or 0.92 mg/kg of butyrate reduces colonization and shedding of S.
enteritidis in the cecum of chickens [43,44]. However, the
mechanism by which butyrate suppresses bacterial growth remain
elusive, although it was proposed to be a result of the direct
antibacterial activity of butyrate [45,46] or a decrease in the
Figure 9. Reduction of the S. enteritidis titer in the cecal
contents of chickens following oral supplementation of
butyrate. In trial 1 (A), 5-day old male broilers were equally divided
into two groups of 10 and fed with a standard antibiotic-free diet mixed
with and without 0.2% sodium butyrate for 2 days. Birds were then
inoculated with 1610
6 CFU of S. enteritidis phage type 13a and
continued with butyrate feeding for another 4 days. The S. enteritidis
titer in the cecal content was quantitated from each animal by serial
plating on Brilliant Green agar plates containing 20 mg/ml nalidixic acid.
Trial 2 (B) was similarly conducted with an additional group of 10
broilers fed with 0.1% butyrate. Each dot represents the bacterial titer
from a bird and the solid line represents the median value of each
treatment. Brackets indicate the statistical significance of differences
(*P=0.03, unpaired Student’s t-test).
doi:10.1371/journal.pone.0027225.g009
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following exposure to butyrate [35,46]. However, because
especially high concentrations of butyrate (25, 50, and 100 mM)
were needed to kill bacteria or negatively impact on bacterial
invasiveness [35,45,46], it is uncertain whether these proposed
mechanisms may occur in vivo, given that most butyrate is
absorbed in the upper digestive tract if supplemented orally
[38,39] and that cecal concentrations of butyrate are only ,6m M
in 18-day-old healthy broiler chickens and ,1 mM in 4-day-old
chickens [46]. More importantly, an increased invasion to
intestinal epithelial cells was observed in the same study when S.
enteritidis was pre-incubated with a mixture of short-chain fatty
acids mimicking the in vivo cecal concentrations [46]. Here, we
uncovered a novel mechanism that we believe accounts primarily
for butyrate-mediated suppression of intestinal bacterial coloniza-
tion. We found that at physiological concentrations butyrate fails
to inhibit bacteria directly, but increase the antibacterial activity of
host innate immune cells by inducing the synthesis of an array of
HDPs with a minimum impact on the phagocytic and oxidative
killing capacity as well as activation status of host cells. Therefore,
it is the production of HDPs that is mainly responsible for a
reduction of bacterial colonization in the intestinal tract of
chickens following oral supplementation of butyrate.
Our in vitro and in vivo studies have firmly established that
butyrate has a strong capacity to induce HDP synthesis and that
supplementation of butyrate can augment disease resistance and
reduce bacterial colonization in chickens. Therefore, the strategies
for efficient delivery of butyrate to the lower intestinal tract will
have important implications in animal health and food safety.
Indeed, the microencapsulated form of butyrate proves to be more
efficient in suppressing bacterial growth in the ceca of chickens
than the free unprotected form [43,44]. Alternatively, identifica-
tion and application of less labile forms of butyrate analogs in the
feed may also prove to be more desirable. In fact, several butyrate
analogs have been shown to be capable of inducing HDP gene
expression in humans [47] and such analogs await further testing
for their antibacterial efficacy in other animal species such as
chickens. Besides direct administration of butyrate and its analogs,
the dietary approaches that promote the proliferation of butyrate-
producing bacteria and stimulate the fermentation of butyrate
through the use of prebiotics may also have good prospect to
augment HDP synthesis and host defense.
In summary, we have revealed that butyrate-induced synthesis
of endogenous HDPs is a phylogenetically conserved mechanism
of innate host defense shared by both mammals and chickens.
Moreover, we propose that butyrate-induced HDP synthesis
represents a newly discovered mechanism that mainly accounts
for the suppression of bacterial colonization and shedding in farm
animals by butyrate. Coupled with anti-inflammatory effects and
other beneficial properties, butyrate, butyrate analogs, and
perhaps other short-chain fatty acids may have potential for
further development as antibiotic-alternative food or feed additives
to boost innate immunity and disease resistance of humans and
animals without provoking a harmful proinflammatory response.
Acknowledgments
We thank Giang H. Pham for her assistance with flow cytometric analysis
and Michael G. Kaiser for technical assistance.
Author Contributions
Conceived and designed the experiments: LTS GZ. Performed the
experiments: LTS MA NBS YRB GD WJ GZ. Analyzed the data: LTS
WJ GZ. Contributed reagents/materials/analysis tools: SL HSL AB RGT.
Wrote the paper: LTS NBS SL HSL GZ.
References
1. Brogden KA, Ackermann M, McCray PB, Jr., Tack BF (2003) Antimicrobial
peptides in animals and their role in host defences. Int J Antimicrob Agents 22:
465–478.
2. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new
anti-infective therapeutic strategies. Nat Biotechnol 24: 1551–1557.
3. Strominger JL (2009) Animal antimicrobial peptides: ancient players in innate
immunity. J Immunol 182: 6633–6634.
4. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004) Multiple
roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin
in host defense. Annu Rev Immunol 22: 181–215.
5. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:
389–395.
6. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev
Immunol 3: 710–720.
7. Lehrer RI (2004) Primate defensins. Nat Rev Microbiol 2: 727–738.
8. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial
immune response. Nat Immunol 6: 551–557.
9. Lai Y, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have
multiple roles in immune defense. Trends Immunol 30: 131–141.
10. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity.
J Leukoc Biol 75: 39–48.
11. Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and
maintenance of intestinal homeostasis. Nat Rev Microbiol 9: 356–368.
12. Lynn DJ, Higgs R, Gaines S, Tierney J, James T, et al. (2004) Bioinformatic
discovery and initial characterisation of nine novel antimicrobial peptide genes
in the chicken. Immunogenetics 56: 170–177.
13. Lynn DJ, Higgs R, Lloyd AT, O’Farrelly C, Herve-Grepinet V, et al. (2007)
Avian beta-defensin nomenclature: a community proposed update. Immunol
Lett 110: 86–89.
14. Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, et al. (2004) A genome-
wide screen identifies a single beta-defensin gene cluster in the chicken:
implications for the origin and evolution of mammalian defensins. BMC
Genomics 5: 56.
15. van Dijk A, Veldhuizen EJ, van Asten AJ, Haagsman HP (2005) CMAP27, a
novel chicken cathelicidin-like antimicrobial protein. Vet Immunol Immuno-
pathol 106: 321–327.
16. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, et al. (2006)
Identification and functional characterization of three chicken cathelicidins with
potent antimicrobial activity. J Biol Chem 281: 2858–2867.
17. Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, et al. (2007) Chicken
cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway. Proc
Natl Acad Sci U S A 104: 15063–15068.
18. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors
in bacteria? Nat Rev Microbiol 3: 238–250.
19. Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, et al. (1994)
Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS
Lett 342: 281–285.
20. Evans EW, Beach FG, Moore KM, Jackwood MW, Glisson JR, et al. (1995)
Antimicrobial activity of chicken and turkey heterophil peptides CHP1, CHP2,
THP1, and THP3. Vet Microbiol 47: 295–303.
21. Higgs R, Lynn DJ, Gaines S, McMahon J, Tierney J, et al. (2005) The synthetic
form of a novel chicken beta-defensin identified in silico is predominantly active
against intestinal pathogens. Immunogenetics 57: 90–98.
22. van Dijk A, Veldhuizen EJ, Kalkhove SI, Tjeerdsma-van Bokhoven JL,
Romijn RA, et al. (2007) The beta-defensin gallinacin-6 is expressed in the
chicken digestive tract and has antimicrobial activity against food-borne
pathogens. Antimicrob Agents Chemother 51: 912–922.
23. Milona P, Townes CL, Bevan RM, Hall J (2007) The chicken host peptides,
gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.
Biochem Biophys Res Commun 356: 169–174.
24. Derache C, Labas V, Aucagne V, Meudal H, Landon C, et al. (2009) Primary
structure and antibacterial activity of chicken bone marrow-derived beta-
defensins. Antimicrob Agents Chemother 53: 4647–4655.
25. Bommineni YR, Dai H, Gong YX, Soulages JL, Fernando SC, et al. (2007)
Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent
antibacterial and lipopolysaccharide-neutralizing activities. FEBS J 274: 418–428.
26. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, et al. (2011) Potential
beneficial effects of butyrate in intestinal and extraintestinal diseases.
World J Gastroenterol 17: 1519–1528.
27. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, et al. (2008)
Review article: the role of butyrate on colonic function. Aliment Pharmacol
Ther 27: 104–119.
Butyrate Induces HDP Gene Expression
PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e2722528. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, et al. (2006) Improved
outcome in shigellosis associated with butyrate induction of an endogenous
peptide antibiotic. Proc Natl Acad Sci U S A 103: 9178–9183.
29. Schauber J, Iffland K, Frisch S, Kudlich T, Schmausser B, et al. (2004) Histone-
deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol
Immunol 41: 847–854.
30. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, et al. (2003)
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in
colonocytes: relevance of signalling pathways. Gut 52: 735–741.
31. Beug H, von Kirchbach A, Doderlein G, Conscience JF, Graf T (1979) Chicken
hematopoietic cells transformed by seven strains of defective avian leukemia
viruses display three distinct phenotypes of differentiation. Cell 18: 375–390.
32. Xiao Y, Herrera AI, Bommineni YR, Soulages JL, Prakash O, et al. (2009) The
central kink region of fowlicidin-2, an alpha-helical host defense peptide, is
critically involved in bacterial killing and endotoxin neutralization. J Innate
Immun 1: 268–280.
33. Xiao Y, Dai H, Bommineni YR, Soulages JL, Gong YX, et al. (2006) Structure-
activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in
chicken. FEBS J 273: 2581–2593.
34. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL (2006) Control of
the innate epithelial antimicrobial response is cell-type specific and dependent on
relevant microenvironmental stimuli. Immunology 118: 509–519.
35. Van Immerseel F, De Buck J, De Smet I, Pasmans F, Haesebrouck F, et al.
(2004) Interactions of butyric acid- and acetic acid-treated Salmonella with
chicken primary cecal epithelial cells in vitro. Avian Dis 48: 384–391.
36. Xie H, Rath NC, Huff GR, Balog JM, Huff WE (2001) Inflammation-induced
changes in serum modulate chicken macrophage function. Vet Immunol
Immunopathol 80: 225–235.
37. Kaiser MG, Lamont SJ (2002) Microsatellites linked to Salmonella enterica
Serovar Enteritidis burden in spleen and cecal content of young F1 broiler-cross
chicks. Poult Sci 81: 657–663.
38. Thompson JL, Hinton M (1997) Antibacterial activity of formic and propionic
acids in the diet of hens on Salmonellas in the crop. Br Poult Sci 38: 59–65.
39. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, et al. (2010) From
the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev
23: 366–384.
40. Joseph J, Mudduluru G, Antony S, Vashistha S, Ajitkumar P, et al. (2004)
Expression profiling of sodium butyrate (NaB)-treated cells: identification of
regulation of genes related to cytokine signaling and cancer metastasis by NaB.
Oncogene 23: 6304–6315.
41. Daly K, Shirazi-Beechey SP (2006) Microarray analysis of butyrate regulated
genes in colonic epithelial cells. DNA Cell Biol 25: 49–62.
42. Schwab M, Reynders V, Loitsch S, Steinhilber D, Schroder O, et al. (2008) The
dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-
2 in intestinal epithelial cells. Immunology 125: 241–251.
43. Fernandez-Rubio C, Ordonez C, Abad-Gonzalez J, Garcia-Gallego A,
Honrubia MP, et al. (2009) Butyric acid-based feed additives help protect
broiler chickens from Salmonella Enteritidis infection. Poult Sci 88: 943–948.
44. Van Immerseel F, Boyen F, Gantois I, Timbermont L, Bohez L, et al. (2005)
Supplementation of coated butyric acid in the feed reduces colonization and
shedding of Salmonella in poultry. Poult Sci 84: 1851–1856.
45. Levison ME (1973) Effect of colon flora and short-chain fatty acids on growth in
vitro of Pseudomonas aeruginsoa and Enterobacteriaceae. Infect Immun 8:
30–35.
46. Van Immerseel F, De Buck J, Pasmans F, Velge P, Bottreau E, et al. (2003)
Invasion of Salmonella enteritidis in avian intestinal epithelial cells in vitro is
influenced by short-chain fatty acids. Int J Food Microbiol 85: 237–248.
47. Steinmann J, Halldorsson S, Agerberth B, Gudmundsson GH (2009)
Phenylbutyrate induces antimicrobial peptide expression. Antimicrob Agents
Chemother 53: 5127–5133.
48. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4
microarray software suite. Methods Enzymol 411: 134–193.
Butyrate Induces HDP Gene Expression
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27225